- BNF:
- 3.2
- Status:
- Grey
- Decision Date:
- None
Comments
Restricted for use in patients who cannot tolerate other inhaled corticosteroids and if a once daily preparation is clinically appropriate for the patient or following respiratory specialist advice as an add-on to current LABA/ICS. (Decision date - February 2016, further decision - October 2019).
Grey Drug Classifications
- 1: Lack of data on effectiveness compared with standard therapy
- 5: Less cost-effective than current standard therapy
search again